The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation. The program, created under the Inflation Reduction Act, allows CMS to directly ...

Eli Lilly says some Medicare Part D plans may not follow the $50 monthly cap for weight‑loss drugs under a new CMS coverage program.

Brown, LLC represented the whistleblower in an approximately $764,000 False Claims Act (FCA) settlement with Troy Sleep Center PLC, Care One Medical Equipment and Supplies, Inc., and their owners. The ...

A top Senate Republican say passing Medicaid work requirements will be an uphill battle. Former Senate President Don Gaetz ...

Part D plans may have deductibles of up to $615 this year. Seniors on 10 popular prescription drugs will pay less for these medications in 2026. Your out-of-pocket maximum on prescription drugs may be ...

AbbVie filed a lawsuit Feb. 11 challenging the federal government’s decision to include Botox in Medicare’s drug price negotiation program. In the complaint filed in the U.S. District Court for the ...

A version of this story first appeared in WFAE Education Reporter James Farrell's weekly newsletter. Sign up here to get newsletters from WFAE straight to your inbox. I spent much of last week working ...

The Inflation Reduction Act (IRA), signed into law on August 16, 2022, allows the federal government to negotiate prices for some high-cost drugs covered under Medicare. Under the law, many small ...

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.

"Depending on what prices CMS sets," writes health expert Sally Pipes, "it may be impossible for biosimilar manufacturers to sell at a price low enough for patients." Officials at the Centers for ...

While the 15 medications selected for the latest round of the federal government’s drug price negotiation program will face steep cuts in what Medicare will pay, the financial impact to pharmaceutical ...

The Centers for Medicare & Medicaid Services has announced the selection of 15 prescription drugs for the third cycle of the Medicare Drug Price Negotiation Program. These are high-cost drugs covered ...